Key result
Elevated resting heart rate linked to ~4.7-fold higher MACE risk in hemodialysis patients.
Why the study?
Existing clinical evidence regarding the association between resting heart rate and major adverse cardiovascular events in patients receiving maintenance hemodialysis remains unclear and inconsistent.
Does elevated resting heart rate predict major adverse cardiovascular events in patients receiving maintenance hemodialysis?
Cohort (n=309)
No
Does elevated resting heart rate predict major adverse cardiovascular events in patients receiving maintenance hemodialysis?
Odds Ratio: 4.7 (95% CI 2.27–9.73)
Absolute Event Rate: 52.6% vs 20.5%
p-value: p=<0.001
Elevated resting heart rate is an independent predictor of major adverse cardiovascular events in patients receiving maintenance hemodialysis, suggesting its utility as a simple, non-invasive prognostic marker for cardiovascular risk stratification.
Background: Existing clinical evidence in the literature regarding the association between resting heart rate (RHR) and major adverse cardiovascular events (MACE) in patients receiving maintenance hemodialysis (MHD) remains unclear and inconsistent. Objective: To determine whether RHR independently predicts major adverse cardiovascular events (MACE) in patients receiving maintenance hemodialysis (MHD). Methods: We conducted a prospective cohort study in which 309 adult MHD patients receiving maintenance hemodialysis were stratified into three groups according to the 33rd and 66th percentiles of baseline RHR. The primary outcome was incidence of MACE. Univariaable and multivariaable logistic regression analyses were performed, followed by internal validation of the final multivariable model using bootstrap resampling. A nomogram, calibration plots, and decision curve analysis (DCA) were used to evaluate model performance and clinical utility. It is noteworthy that heart failure events were identified based on the documented clinical diagnosis made by the treating physician after comprehensive assessment of symptoms, signs, medical history, and available investigations. Although BNP measurements and echocardiographic assessments were not available for all patients, their absence did not preclude a clinical diagnosis of heart failure in routine practice. Results: < 0.001). In the multivariable model, higher RHR (T2: odds ratio [OR] = 2.09; T3: OR = 4.70), higher Hospital Anxiety and Depression Scale (HADS) score (8-10: OR = 6.40; >10: OR = 2.04), diabetes (OR = 6.52), elevated intact parathyroid hormone (iPTH) (OR = 1.001), and lower uric acid (OR = 0.74) were identified as independent predictors of total MACE. The nomogram demonstrated good discrimination (area under the curve [AUC] = 0.820, specificity = 0.843, and sensitivity = 0.652), with good calibration and potential clinical utility demonstrated by calibration plots and DCA. Conclusion: In this single-center cohort of patients receiving maintenance hemodialysis, elevated RHR was independently associated with an increased risk of MACE after adjustment for psychosocial and metabolic factors, including HADS score, diabetes, uric acid, and iPTH. Incorporating RHR and these clinical variables into a risk model may facilitate early identification of high-risk patients for targeted intervention, although external validation is required before broader clinical application.
No takes yet. Share an insight, caveat, or question.
Tong et al. (2026) conducted a cohort in End-stage kidney disease receiving maintenance hemodialysis (n=309). Elevated resting heart rate vs. Lower resting heart rate (≤71 bpm) was evaluated on Major adverse cardiovascular events (MACE) (OR 4.70, 95% CI 2.27-9.73, p=<0.001). In patients receiving maintenance hemodialysis, an elevated resting heart rate (≥84 bpm) was independently associated with an increased risk of major adverse cardiovascular events (OR 4.70).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: